User profiles for Sven-Erik Strand

Sven-Erik Strand

Lund University
Verified email at med.lu.se
Cited by 8387

A Monte Carlo program for the simulation of scintillation camera characteristics

M Ljungberg, SE Strand - Computer methods and programs in biomedicine, 1989 - Elsevier
There is a need for mathematical modelling for the evaluation of important parameters for
photon imaging systems. A Monte Carlo program which simulates medical imaging nuclear …

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

…, R Perfekt, R Perfekt, J Wennerberg, SE Strand - Head & …, 2002 - Wiley Online Library
Background Positron emission tomography (PET) provides metabolic information of tissues
in vivo. The purpose of this study was to assess the value of PET with 2‐[ 18 F] fluoro‐2‐…

177Lu‐[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy

…, M Ljungberg, T Ohlsson, K Wingårdh, SE Strand… - Cancer, 2010 - Wiley Online Library
BACKGROUND: 177 Lu‐(DOTA0,Tyr3) octreotate is a new treatment modality for disseminated
neuroendocrine tumors. According to a consensus protocol, the calculated maximally …

[BOOK][B] Monte Carlo calculations in nuclear medicine: Applications in diagnostic imaging

M Ljungberg, SE Strand, MA King - 2012 - books.google.com
Sven-Erik Strand is a professor in medical radiation physics at Lund University. He received
his Master of Science degree at the science faculty in 1972, his medical bachelor‘s degree …

99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes

…, S Fredriksson, L Knutsson, SE Strand - Journal of Nuclear …, 2012 - Soc Nuclear Med
The purpose of this study was to develop multimodality SPECT/MRI contrast agents for sentinel
lymph node (SLN) mapping in vivo. Methods: Nanoparticles with a solid iron oxide core …

Particle sizing and biokinetics of interstitiallymphoscintigraphic agents

L Bergqvist, SE Strand, BRR Persson - Seminars in nuclear medicine, 1983 - Elsevier
The biokinetics of inert lymphoscintigraphic agentsstrongly depends on their particle size.
Different techniques for characterization of colloids are discussed. Experiments have been …

The impact of PET and SPECT on dosimetry for targeted radionuclide therapy

…, M Monsieurs, S Savolainen, SE Strand… - … für medizinische Physik, 2006 - Elsevier
Targeted radionuclide therapy (TRT) is an increasingly used treatment modality for a range
of cancers. To date, few treatments have involved the use of dosimetry either to plan …

Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody …

…, H Horne, T Ohlsson, L Stenberg, SE Strand… - Clinical Cancer …, 2005 - AACR
Purpose: Fractionated radioimmunotherapy may improve therapeutic outcome by decreasing
heterogeneity of the dose delivered to the tumor and by decreasing hematologic toxicity, …

Radiation dosimetry in nuclear medicine

…, SR Thomas, M Ljungberg, SE Strand - Applied Radiation and …, 1999 - Elsevier
Radionuclides are used in nuclear medicine in a variety of diagnostic and therapeutic
procedures. A knowledge of the radiation dose received by different organs in the body is …

A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for 131I using Monte Carlo simulation

…, X Liu, E Frey, Y Dewaraja, SE Strand - Journal of Nuclear …, 2002 - Soc Nuclear Med
A general method is presented for patient-specific 3-dimensional absorbed dose calculations
based on quantitative SPECT activity measurements. Methods: The computational scheme …